<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-17168</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0073671</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories>
<title-group>
<article-title>Association of Interleukin-18 Gene Promoter −607 C&gt;A and −137G&gt;C Polymorphisms with Cancer Risk: A Meta-Analysis of 26 Studies</article-title>
<alt-title alt-title-type="running-head">IL-18-607 C&gt;A and −137G&gt;C and Cancer Risk</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Qiu</surname><given-names>Man-Tang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>Jing-Wen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jiang</surname><given-names>Feng</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>Ming</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>Qin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yin</surname><given-names>Rong</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>The First Clinical College of Nanjing Medical University, Nanjing, China</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Cancer Institute of Jiangsu Province, Nanjing, China</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>The Fourth Clinical College of Nanjing Medical University, Nanjing, China</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Scientific Research, Nanjing Medical University Affiliated Cancer Hospital, Cancer Institute of Jiangsu Province, Nanjing, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Chammas</surname><given-names>Roger</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Faculdade de Medicina, Universidade de São Paulo, Brazil</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">xulin83cn@gmail.com</email> (LX); <email xlink:type="simple">yinhero001@126.com</email> (RY)</corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: XY MTQ JWH FJ RY LX. Performed the experiments: XY MTQ FJ RY JW QZ. Analyzed the data: XY MTQ JWH RY LX. Contributed reagents/materials/analysis tools: XY MTQ ML JW RY QZ. Wrote the paper: XY MTQ QZ RY LX.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>16</day><month>9</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>9</issue>
<elocation-id>e73671</elocation-id>
<history>
<date date-type="received"><day>26</day><month>4</month><year>2013</year></date>
<date date-type="accepted"><day>19</day><month>7</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Yang et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Background</title>
<p>Evidence suggest that IL-18 gene polymorphisms may be risk factors for several cancers. Increasing studies investigating the association between IL-18 gene promoter polymorphisms (−607 C&gt;A and −137G&gt;C) and cancer risk have yielded conflicting results.</p>
</sec><sec>
<title>Methodology/Principal Findings</title>
<p>We performed a meta-analysis of 26 studies including 4096 cases and 5222 controls. We assessed the strength of the association of IL-18 gene promoter −607 C&gt;A and −137G&gt;C polymorphisms with cancer risk and performed sub-group analyses by cancer types, ethnicities, source of controls and sample size. The pooled results revealed a significant increased risk of cancer susceptibility for −607 C&gt;A (CA vs. CC: OR = 1.19, 95%CI: 1.04, 1.37, P<sub>heterogeneity</sub> = 0.033; CA/AA vs. CC: OR = 1.17, 95% CI: 1.01, 1.34, P<sub>heterogeneity</sub> = 0.007), but no significant association for −137 G&gt;C was observed with overall cancer risk. Sub-group analyses revealed that an increased risk of nasopharyngeal carcinoma was both found for −607 C&gt;A (CA/AA vs. CC: OR = 1.32, 95% CI: 1.04, 1.69, P<sub>heterogeneity</sub> = 0.823) and −137G&gt;C (GC/CC vs. GG: OR = 1.57, 95%CI: 1.26, 1.96, P<sub>heterogeneity</sub> = 0.373). Consistent with the results of the genotyping analyses, the −607A/−137C and −607C/−137C haplotypes were associated with a significantly increased risk of nasopharyngeal carcinoma as compared with the −607C/−137G haplotype (−607A/−137C vs. −607C/−137G: OR = 1.26, 95%CI: 1.13, 1.40; P<sub>heterogeneity</sub> = 0.569; −607C/−137C vs. −607C/−137G: OR = 1.14, 95%CI: 1.03, 1.27; P<sub>heterogeneity</sub> = 0.775). As for gastrointestinal cancer, we also found that −607 C&gt;A polymorphism was significantly associated with increased cancer risk (CA/AA vs. CC: OR = 1.25, 95% CI: 1.05, 1.50, P<sub>heterogeneity</sub> = 0.458). Further sub-group analysis revealed that −137G&gt;C polymorphism contributed to cancer risk in Asians but not in Caucasians (GC/CC vs. GG: OR = 1.31, 95%CI: 1.05, 1.64, P<sub>heterogeneity</sub>&lt;0.001).</p>
</sec><sec>
<title>Conclusions</title>
<p>The meta-analysis results suggest that IL-18 gene promoter −607 C&gt;A polymorphism is significantly associated with overall cancer risk, especially in nasopharyngeal carcinoma and gastrointestinal cancer; and the −137 G&gt;C polymorphism is associated with increased overall cancer risk in Asian populations and also significantly increases the risk of nasopharyngeal carcinoma.</p>
</sec></abstract>
<funding-group><funding-statement>This work was supported by the National Natural Science Foundation of China (81201830) and Natural Science Foundation of Jiangsu Province (BK2010589, BK2011857), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="11"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Interleukin-18 (IL-18) is a member of the IL-1 cytokine family, and it is initially described as IFN-γ inducing factor <xref ref-type="bibr" rid="pone.0073671-Chang1">[1]</xref>. IL-18 is produced by various cells, including T and B cells, and a range of antigen-presenting cells including activated monocytes, dendritic cells and macrophages, which can regulate both innate and adaptive immune responses <xref ref-type="bibr" rid="pone.0073671-Tschoeke1">[2]</xref>, <xref ref-type="bibr" rid="pone.0073671-Srivastava1">[3]</xref>. Evidence has indicated that IL-18 might possess anticancer function. IL-18 can stimulate natural killer cells and T cells promoting primarily Th1 response, which is able to increase the immune defense against tumor cells by activating and inducing the production of IFN-γ <xref ref-type="bibr" rid="pone.0073671-Gunel1">[4]</xref>. The mechanisms of the host defense against cancer are very complex, including suppression of tumor growth <xref ref-type="bibr" rid="pone.0073671-Iwasaki1">[5]</xref>, induction of cancer cell apoptosis <xref ref-type="bibr" rid="pone.0073671-Okano1">[6]</xref>, and inhibition of angiogenesis <xref ref-type="bibr" rid="pone.0073671-Park1">[7]</xref>. However, IL-18 has also been found to promote tumor progression. Higher expression of IL-18 is detected in various cancer cells compared with normal control, and IL-18 is able to induce angiogenesis, migration, proliferation and immune escape <xref ref-type="bibr" rid="pone.0073671-Park2">[8]</xref>. These findings confirm the evidence of an association between IL-18 gene and cancer risk but remain controversial.</p>
<p>The IL-18 gene is located on chromosome 11q22.2–q22.3, and contains many polymorphisms, especially in the promoter region. The variations in IL-18 gene promoter are able to influence IL-18 production and activity. The IL-18 gene promoter −607 C&gt;A (rs1946518) and −137 G&gt;C (rs187238) polymorphisms are two of the most common single nucleotide polymorphisms (SNPs). The −607 C&gt;A can alter a cAMP-responsible element binding site, and result in a decrease of IL-18 transcription <xref ref-type="bibr" rid="pone.0073671-Giedraitis1">[9]</xref>. The −137 G&gt;C can change the binding site of histone 4 transcription factor-1(H4TF-1) nuclear factor. Additionally, cloning and gene expression analysis showed that the polymorphisms in IL-18 promoter region caused the differences in transcription factor binding and had an impact on IL-18 gene activity <xref ref-type="bibr" rid="pone.0073671-Giedraitis1">[9]</xref>. Recently, The IL-18 gene polymorphisms have been investigated in several cancers such as nasopharyngeal carcinoma <xref ref-type="bibr" rid="pone.0073671-Pratesi1">[10]</xref>, <xref ref-type="bibr" rid="pone.0073671-Farhat1">[11]</xref>, prostate cancer <xref ref-type="bibr" rid="pone.0073671-Liu1">[12]</xref>, colorectal cancer <xref ref-type="bibr" rid="pone.0073671-Nikiteas1">[13]</xref>, esophageal carcinoma <xref ref-type="bibr" rid="pone.0073671-Wei1">[14]</xref>, cervical cancer <xref ref-type="bibr" rid="pone.0073671-Qi1">[15]</xref>, breast cancer <xref ref-type="bibr" rid="pone.0073671-KhaliliAzad1">[16]</xref> and so on. However, these studies yielded different or even controversial results.</p>
<p>Meta-analysis is a means of increasing the effective sample size under investigation through the pooling of data from individual studies, thus enhancing the statistical power of the analysis for the estimation of genetic effects <xref ref-type="bibr" rid="pone.0073671-Pan1">[17]</xref>. To clarify the association between IL-18 gene promoter polymorphisms and cancer risk, we performed this meta-analysis by pooling eligible studies to calculate the estimate of overall cancer risk and evaluated influence of cancer types, ethnicity, source of controls and sample size.</p>
</sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>Search Strategy</title>
<p>According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), we conducted a systematic literature search using the databases PubMed, EMBASE and CNKI (Chinese National Knowledge Infrastructure) without language, time period and sample size limitations, covering all papers published up to April 10, 2013, with a combination of the following key words: IL-18 gene (e.g.: “IL-18”, and “Interleukin-18”); cancer (e.g.: “cancer”, “carcinoma”, “tumor” or “neoplasms”) and polymorphism or variation. Furthermore, all searched papers including reviews were retrieved, and their references were checked as well for other relevant publications.</p>
</sec><sec id="s2b">
<title>Inclusion and Exclusion Criteria</title>
<p>The following criteria were used for the literature selection: (a) only the case–control studies were considered; (b) the association of cancer risk with −607 C&gt;A and −137 G&gt;C polymorphisms was clearly investigated; (c) sufficient genotype distribution information in cases and controls. The major reasons for exclusion of studies were (a) reviews and repeated literature; (b) study design other than case-control method; (c) studies without detailed genotype frequencies.</p>
</sec><sec id="s2c">
<title>Data Extraction</title>
<p>The following information was independently extracted from each study by two authors (Yang and Qiu) according to the selection criteria mentioned above: name of first author, publication year, country where the study was conducted, ethnicity, source of controls, cancer types, genotyping methods, genotype frequency in cases and controls. Different ethnicities were categorized as Asian, Caucasian, and African. Cancer types were classified as Gynecological cancer (GC), including cervical cancer, ovarian cancer, choriocarcinoma; Genitourinary system cancer (GUC), including prostate cancer, renal cell carcinoma and bladder cancer; Gastrointestinal cancer (GIC), including esophageal carcinoma, stomach cancer and colorectal cancer; Nasopharyngeal carcinoma (NC); Breast cancer (BC) and Others (oral cancer, head and neck carcinoma, lung cancer). All eligible studies were defined as hospital-based (HB) and population-based (PB) according to the source of controls. The Hardy–Weinberg equilibrium (HWE) were calculated by Chi-square test (p&lt;0.05 was considered as significant disequilibrium) based on the two polymorphisms genotyping distribution in controls <xref ref-type="bibr" rid="pone.0073671-Qiu1">[18]</xref>.</p>
</sec><sec id="s2d">
<title>Statistical Analysis</title>
<p>Odds ratio (OR) with 95% confidence intervals (CIs) was used to assess the strength of association between IL-18 gene promoter polymorphisms (−607 C&gt;A and −137G&gt;C) and cancer risk, based on the genotype frequencies in cases and controls. A 95% CI was used for statistical significance test and it without 1 for OR indicating a significant increased or reduced cancer risk. The pooled ORs were calculated for four models respectively: homozygote comparison (AA vs. CC; CC vs. GG), heterozygote comparison (CA vs. CC; GC vs. GG), dominant model (CA/AA vs. CC; GC/CC vs. GG) and recessive model (AA vs. CC/CA; CC vs. GG/GC). The haplotypes were divided into four categories: −607A/−137C, −607A/−137G, −607C/−137C and −607C/−137G. Fixed-effects model (Mantel-Haenszel method) was adopted when P<sub>heterogeneity</sub> was more than 0.10, while random-effects model (the Der Simonian and Laird method) was more appropriate when P<sub>heterogeneity</sub> was less than 0.10 <xref ref-type="bibr" rid="pone.0073671-Boissel1">[19]</xref>, <xref ref-type="bibr" rid="pone.0073671-Lau1">[20]</xref>. Sensitivity analysis was conducted by removing one data set at a time to identify individual study’ effect on pooled results and test the reliability of results <xref ref-type="bibr" rid="pone.0073671-Qiu1">[18]</xref>. The heterogeneity between these studies was checked using Chi-square based Q test and it was considered statistically significant when P-value was less than 0.10. Sub-group analyses and logistic meta-regression analyses were conducted to explore the source of heterogeneity among variables, such as years, cancer types, ethnicities, source of controls and sample size (studies with more than 500 participants were defined as “large”, and studies with less 500 participants were defined as “small”). Begg’s funnel plots <xref ref-type="bibr" rid="pone.0073671-Begg1">[21]</xref> and Egger’s regression method <xref ref-type="bibr" rid="pone.0073671-Egger1">[22]</xref> were conducted to detect the potential publication bias (P&lt;0.05 was considered representative of statistically significant publication bias). All P values are two-sided. Statistical analysis was done using STATA software (version 12.1; Stata Corp, College Station, Texas USA).</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Characteristics of Studies</title>
<p>The detailed study selection process was shown in <xref ref-type="fig" rid="pone-0073671-g001">Figure 1</xref>. In the study reported by Haghshenas and colleagues, the cancer types contained colorectal and stomach cancer, and the genotype frequencies were presented separately, thus each of them was considered as a separate study in this meta-analysis. A total of 23 studies for −607 C&gt;A and 21 studies for −137G&gt;C were finally included with 4096 cases and 5222 controls according to selection criteria<xref ref-type="bibr" rid="pone.0073671-Pratesi1">[10]</xref>–<xref ref-type="bibr" rid="pone.0073671-KhaliliAzad1">[16]</xref>, <xref ref-type="bibr" rid="pone.0073671-Bushley1">[23]</xref>–<xref ref-type="bibr" rid="pone.0073671-Liu2">[40]</xref>. The detailed characteristics of the eligible studies included in this meta-analysis are shown in <xref ref-type="table" rid="pone-0073671-t001">Table 1</xref>.</p>
<fig id="pone-0073671-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0073671.g001</object-id><label>Figure 1</label><caption>
<title>PRISMA Flow Chart.</title>
<p>*Two separate studies were reported in one article, thus 23 studies on −607 C&gt;A and 21 studies on −137 G&gt;C were eligible.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0073671.g001" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0073671-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0073671.t001</object-id><label>Table 1</label><caption>
<title>Characteristics of Eligible Studies.</title>
</caption><alternatives><graphic id="pone-0073671-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0073671.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Firstauthor</td>
<td align="left" rowspan="1" colspan="1">Year</td>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1">Control</td>
<td align="left" rowspan="1" colspan="1">Cancer types</td>
<td align="left" rowspan="1" colspan="1">Genotypingmethod</td>
<td colspan="7" align="left" rowspan="1">−607 C&gt;A</td>
<td colspan="7" align="left" rowspan="1">−137 G&gt;C</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">Cases</td>
<td colspan="3" align="left" rowspan="1">Controls</td>
<td align="left" rowspan="1" colspan="1">HWE</td>
<td colspan="3" align="left" rowspan="1">Cases</td>
<td colspan="3" align="left" rowspan="1">Controls</td>
<td align="left" rowspan="1" colspan="1">HWE</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1">CA</td>
<td align="left" rowspan="1" colspan="1">AA</td>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1">CA</td>
<td align="left" rowspan="1" colspan="1">AA</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">GG</td>
<td align="left" rowspan="1" colspan="1">GC</td>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1">GG</td>
<td align="left" rowspan="1" colspan="1">GC</td>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Bushley</bold></td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">ovarian cancer</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">127</td>
<td align="left" rowspan="1" colspan="1">48</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">139</td>
<td align="left" rowspan="1" colspan="1">71</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.99</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Pratesi</bold></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">nasopharyngealcarcinoma</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">42</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">43</td>
<td align="left" rowspan="1" colspan="1">64</td>
<td align="left" rowspan="1" colspan="1">23</td>
<td align="left" rowspan="1" colspan="1">0.92</td>
<td align="left" rowspan="1" colspan="1">43</td>
<td align="left" rowspan="1" colspan="1">39</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.21</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Liu</bold></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">prostate cancer</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">143</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">137</td>
<td align="left" rowspan="1" colspan="1">78</td>
<td align="left" rowspan="1" colspan="1">0.75</td>
<td align="left" rowspan="1" colspan="1">149</td>
<td align="left" rowspan="1" colspan="1">96</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">195</td>
<td align="left" rowspan="1" colspan="1">73</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">0.13</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Nikiteas</bold></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">32</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Wei</bold></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">esophagealsquamous cellcarcinoma</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">48</td>
<td align="left" rowspan="1" colspan="1">123</td>
<td align="left" rowspan="1" colspan="1">64</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td align="left" rowspan="1" colspan="1">124</td>
<td align="left" rowspan="1" colspan="1">67</td>
<td align="left" rowspan="1" colspan="1">0.91</td>
<td align="left" rowspan="1" colspan="1">127</td>
<td align="left" rowspan="1" colspan="1">91</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">176</td>
<td align="left" rowspan="1" colspan="1">66</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.56</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Vairaktaris</bold></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">oral cancer</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">55</td>
<td align="left" rowspan="1" colspan="1">66</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">32</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Yang</bold></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">cervical cancer</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Sobti</bold></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">cervical cancer</td>
<td align="left" rowspan="1" colspan="1">PCR-SSP</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">89</td>
<td align="left" rowspan="1" colspan="1">104</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">114</td>
<td align="left" rowspan="1" colspan="1">74</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Farhat</bold></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">African</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">nasopharyngealcarcinoma</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">77</td>
<td align="left" rowspan="1" colspan="1">34</td>
<td align="left" rowspan="1" colspan="1">0.54</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">73</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">83</td>
<td align="left" rowspan="1" colspan="1">68</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">0.86</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Kashef</bold></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">choriocarcinoma</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">54</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">0.43</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">56</td>
<td align="left" rowspan="1" colspan="1">39</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.74</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Qi</bold></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">cervical cancer</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.92</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Khalili</bold></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">breast cancer</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">64</td>
<td align="left" rowspan="1" colspan="1">103</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">76</td>
<td align="left" rowspan="1" colspan="1">97</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">0.83</td>
<td align="left" rowspan="1" colspan="1">141</td>
<td align="left" rowspan="1" colspan="1">96</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">110</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">0.03</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Asefi</bold></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">head and necksquamous cellcarcinoma</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">43</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">82</td>
<td align="left" rowspan="1" colspan="1">101</td>
<td align="left" rowspan="1" colspan="1">29</td>
<td align="left" rowspan="1" colspan="1">0.81</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">37</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">116</td>
<td align="left" rowspan="1" colspan="1">79</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">0.50</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Haghshenas</bold></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">stomach cancer</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">31</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">119</td>
<td align="left" rowspan="1" colspan="1">144</td>
<td align="left" rowspan="1" colspan="1">48</td>
<td align="left" rowspan="1" colspan="1">0.68</td>
<td align="left" rowspan="1" colspan="1">56</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">167</td>
<td align="left" rowspan="1" colspan="1">109</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Haghshenas</bold></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">55</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">119</td>
<td align="left" rowspan="1" colspan="1">144</td>
<td align="left" rowspan="1" colspan="1">48</td>
<td align="left" rowspan="1" colspan="1">0.68</td>
<td align="left" rowspan="1" colspan="1">83</td>
<td align="left" rowspan="1" colspan="1">55</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">167</td>
<td align="left" rowspan="1" colspan="1">109</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Samsami</bold></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">ovarian cancer</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">51</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">57</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">0.87</td>
<td align="left" rowspan="1" colspan="1">46</td>
<td align="left" rowspan="1" colspan="1">34</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">81</td>
<td align="left" rowspan="1" colspan="1">57</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Nong</bold></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">nasopharyngealcarcinoma</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">132</td>
<td align="left" rowspan="1" colspan="1">71</td>
<td align="left" rowspan="1" colspan="1">69</td>
<td align="left" rowspan="1" colspan="1">133</td>
<td align="left" rowspan="1" colspan="1">68</td>
<td align="left" rowspan="1" colspan="1">0.81</td>
<td align="left" rowspan="1" colspan="1">140</td>
<td align="left" rowspan="1" colspan="1">88</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">189</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">0.17</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Farjadfar</bold></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">lung cancer</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">45</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">46</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">0.68</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.37</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Saenz</bold></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">renal cellcarcinoma</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td align="left" rowspan="1" colspan="1">76</td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">166</td>
<td align="left" rowspan="1" colspan="1">261</td>
<td align="left" rowspan="1" colspan="1">73</td>
<td align="left" rowspan="1" colspan="1">0.07</td>
<td align="left" rowspan="1" colspan="1">91</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">251</td>
<td align="left" rowspan="1" colspan="1">220</td>
<td align="left" rowspan="1" colspan="1">31</td>
<td align="left" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Monroy</bold></td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">hodgkin disease</td>
<td align="left" rowspan="1" colspan="1">MassARRAY</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">85</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">42</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.36</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Taheri</bold></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">breast cancer</td>
<td align="left" rowspan="1" colspan="1">T-ARMS</td>
<td align="left" rowspan="1" colspan="1">29</td>
<td align="left" rowspan="1" colspan="1">32</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">45</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.35</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Babar</bold></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">esophagealadenocarcinoma</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">384</td>
<td align="left" rowspan="1" colspan="1">508</td>
<td align="left" rowspan="1" colspan="1">178</td>
<td align="left" rowspan="1" colspan="1">83</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
<td align="left" rowspan="1" colspan="1">105</td>
<td align="left" rowspan="1" colspan="1">74</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">582</td>
<td align="left" rowspan="1" colspan="1">414</td>
<td align="left" rowspan="1" colspan="1">86</td>
<td align="left" rowspan="1" colspan="1">0.31</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Guo</bold></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">85</td>
<td align="left" rowspan="1" colspan="1">49</td>
<td align="left" rowspan="1" colspan="1">42</td>
<td align="left" rowspan="1" colspan="1">76</td>
<td align="left" rowspan="1" colspan="1">42</td>
<td align="left" rowspan="1" colspan="1">0.53</td>
<td align="left" rowspan="1" colspan="1">91</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">112</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">0.21</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Du</bold></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">nasopharyngealcarcinoma</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">80</td>
<td align="left" rowspan="1" colspan="1">34</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">93</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">0.64</td>
<td align="left" rowspan="1" colspan="1">88</td>
<td align="left" rowspan="1" colspan="1">51</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">131</td>
<td align="left" rowspan="1" colspan="1">43</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.30</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Jaiswal</bold></td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">bladder cancer</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">81</td>
<td align="left" rowspan="1" colspan="1">89</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td align="left" rowspan="1" colspan="1">61</td>
<td align="left" rowspan="1" colspan="1">113</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">0.18</td>
<td align="left" rowspan="1" colspan="1">82</td>
<td align="left" rowspan="1" colspan="1">112</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">118</td>
<td align="left" rowspan="1" colspan="1">77</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Liu</bold></td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">prostate cancer</td>
<td align="left" rowspan="1" colspan="1">AS-PCR</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">172</td>
<td align="left" rowspan="1" colspan="1">103</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">196</td>
<td align="left" rowspan="1" colspan="1">110</td>
<td align="left" rowspan="1" colspan="1">0.71</td>
<td align="left" rowspan="1" colspan="1">301</td>
<td align="left" rowspan="1" colspan="1">74</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">304</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">0.06</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>PB: population-based; HB: hospital-based; HWE: Hardy–Weinberg equilibrium.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b">
<title>Association of −607 C&gt;A with Cancers Risk</title>
<p>As shown in <xref ref-type="table" rid="pone-0073671-t002">Table 2</xref>, we observed a significant increased risk of cancer susceptibility in heterozygote comparison (CA vs. CC: OR = 1.19, 95%CI: 1.04, 1.37; P<sub>heterogeneity</sub> = 0.033) and dominant model (CA/AA vs. CC: OR = 1.17, 95% CI: 1.01, 1.34; P<sub>heterogeneity</sub> = 0.007, <xref ref-type="fig" rid="pone-0073671-g002">Figure 2</xref>) when all eligible studies were pooled. However, we found no significant association in homozygote comparison (AA vs. CC: OR = 1.11, 95%CI: 0.92, 1.33; P<sub>heterogeneity</sub> = 0.013) or recessive model (AA vs. CC/CA: OR = 0.99, 95% CI: 0.85, 1.15; P<sub>heterogeneity</sub> = 0.032).</p>
<fig id="pone-0073671-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0073671.g002</object-id><label>Figure 2</label><caption>
<title>Forest plot of −607 C&gt;A dominant model for overall comparison by cancer types (CA/AA vs. CC).</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0073671.g002" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0073671-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0073671.t002</object-id><label>Table 2</label><caption>
<title>Results from meta-analysis of −607 C&gt;A and cancer risk.</title>
</caption><alternatives><graphic id="pone-0073671-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0073671.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">AA vs. CC</td>
<td colspan="3" align="left" rowspan="1">CA vs. CC</td>
<td colspan="2" align="left" rowspan="1">CA/AA vs. CC</td>
<td colspan="2" align="left" rowspan="1">AA vs. CC/CA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
<td colspan="2" align="left" rowspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Total</bold></td>
<td align="left" rowspan="1" colspan="1">23</td>
<td align="left" rowspan="1" colspan="1">1.11(0.92, 1.33)</td>
<td align="left" rowspan="1" colspan="1">0.013</td>
<td colspan="2" align="left" rowspan="1">1.19(1.04, 1.37)<xref ref-type="table-fn" rid="nt103">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.033</td>
<td align="left" rowspan="1" colspan="1">1.17(1.01, 1.34)<xref ref-type="table-fn" rid="nt103">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.007</td>
<td align="left" rowspan="1" colspan="1">0.99(0.85, 1.15)</td>
<td align="left" rowspan="1" colspan="1">0.032</td>
</tr>
<tr>
<td colspan="11" align="left" rowspan="1"><bold>Cancer Types</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>GC</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.41(0.36, 5.45)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td colspan="2" align="left" rowspan="1">1.45(0.97, 2.18)</td>
<td align="left" rowspan="1" colspan="1">0.525</td>
<td align="left" rowspan="1" colspan="1">1.41(0.67, 2.95)</td>
<td align="left" rowspan="1" colspan="1">0.018</td>
<td align="left" rowspan="1" colspan="1">1.12(0.33, 3.81)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>NC</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.31(0.96, 1.77)</td>
<td align="left" rowspan="1" colspan="1">0.759</td>
<td colspan="2" align="left" rowspan="1">1.33(1.03, 1.72)<xref ref-type="table-fn" rid="nt103">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.704</td>
<td align="left" rowspan="1" colspan="1">1.32(1.04, 1.69)<xref ref-type="table-fn" rid="nt103">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.823</td>
<td align="left" rowspan="1" colspan="1">1.08(0.84, 1.39)</td>
<td align="left" rowspan="1" colspan="1">0.547</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>GUC</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.87(0.67, 1.12)</td>
<td align="left" rowspan="1" colspan="1">0.363</td>
<td colspan="2" align="left" rowspan="1">0.86(0.63, 1.16)</td>
<td align="left" rowspan="1" colspan="1">0.068</td>
<td align="left" rowspan="1" colspan="1">0.85(0.64, 1.13)</td>
<td align="left" rowspan="1" colspan="1">0.076</td>
<td align="left" rowspan="1" colspan="1">0.94(0.77, 1.15)</td>
<td align="left" rowspan="1" colspan="1">0.914</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>GIC</bold></td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">1.12(0.88, 1.42)</td>
<td align="left" rowspan="1" colspan="1">0.648</td>
<td colspan="2" align="left" rowspan="1">1.32(1.08, 1.63)<xref ref-type="table-fn" rid="nt103">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.327</td>
<td align="left" rowspan="1" colspan="1">1.25(1.05, 1.50)<xref ref-type="table-fn" rid="nt103">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.458</td>
<td align="left" rowspan="1" colspan="1">0.95(0.78, 1.17)</td>
<td align="left" rowspan="1" colspan="1">0.681</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>BC</bold></td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">1.33(0.80, 2.22)</td>
<td align="left" rowspan="1" colspan="1">0.438</td>
<td colspan="2" align="left" rowspan="1">1.17(0.81, 1.68)</td>
<td align="left" rowspan="1" colspan="1">0.532</td>
<td align="left" rowspan="1" colspan="1">1.20(0.85, 1.70)</td>
<td align="left" rowspan="1" colspan="1">0.784</td>
<td align="left" rowspan="1" colspan="1">1.23(0.72, 2.10)</td>
<td align="left" rowspan="1" colspan="1">0.274</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Others</bold></td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">1.26(0.61, 2.62)</td>
<td align="left" rowspan="1" colspan="1">0.080</td>
<td colspan="2" align="left" rowspan="1">1.43(0.85, 2.42)</td>
<td align="left" rowspan="1" colspan="1">0.100</td>
<td align="left" rowspan="1" colspan="1">1.37(0.79, 2.39)</td>
<td align="left" rowspan="1" colspan="1">0.055</td>
<td align="left" rowspan="1" colspan="1">0.98(0.62, 1.56)</td>
<td align="left" rowspan="1" colspan="1">0.277</td>
</tr>
<tr>
<td colspan="11" align="left" rowspan="1"><bold>Ethnicities</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Asian</bold></td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">1.15(0.90, 1.46)</td>
<td align="left" rowspan="1" colspan="1">0.003</td>
<td align="left" rowspan="1" colspan="1">1.15(0.98, 1.34)</td>
<td colspan="2" align="left" rowspan="1">0.099</td>
<td align="left" rowspan="1" colspan="1">1.15(0.97, 1.37)</td>
<td align="left" rowspan="1" colspan="1">0.010</td>
<td align="left" rowspan="1" colspan="1">1.04(0.85, 1.25)</td>
<td align="left" rowspan="1" colspan="1">0.011</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Caucasian</bold></td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">1.02(0.78, 1.34)</td>
<td align="left" rowspan="1" colspan="1">0.473</td>
<td align="left" rowspan="1" colspan="1">1.29(0.91, 1.85)</td>
<td colspan="2" align="left" rowspan="1">0.041</td>
<td align="left" rowspan="1" colspan="1">1.20(0.89, 1.62)</td>
<td align="left" rowspan="1" colspan="1">0.083</td>
<td align="left" rowspan="1" colspan="1">0.89(0.70, 1.14)</td>
<td align="left" rowspan="1" colspan="1">0.620</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>African</bold></td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">1.06(0.56, 2.03)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1.58(0.95, 2.62)</td>
<td colspan="2" align="left" rowspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1.42(0.88, 2.30)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">0.79(0.46, 1.38)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td colspan="11" align="left" rowspan="1"><bold>Source of Controls</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>PB</bold></td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">1.01(0.83, 1.23)</td>
<td align="left" rowspan="1" colspan="1">0.196</td>
<td align="left" rowspan="1" colspan="1">1.18(1.01, 1.37)<xref ref-type="table-fn" rid="nt103">*</xref></td>
<td colspan="2" align="left" rowspan="1">0.189</td>
<td align="left" rowspan="1" colspan="1">1.12(0.97, 1.29)</td>
<td align="left" rowspan="1" colspan="1">0.190</td>
<td align="left" rowspan="1" colspan="1">0.91(0.76, 1.09)</td>
<td align="left" rowspan="1" colspan="1">0.154</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>HB</bold></td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">1.33(0.92, 1.91)</td>
<td align="left" rowspan="1" colspan="1">0.009</td>
<td align="left" rowspan="1" colspan="1">1.25(0.94, 1.65)</td>
<td colspan="2" align="left" rowspan="1">0.018</td>
<td align="left" rowspan="1" colspan="1">1.30(0.96, 1.75)</td>
<td align="left" rowspan="1" colspan="1">0.002</td>
<td align="left" rowspan="1" colspan="1">1.14(0.87, 1.48)</td>
<td align="left" rowspan="1" colspan="1">0.044</td>
</tr>
<tr>
<td colspan="11" align="left" rowspan="1"><bold>Sample Size</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Large<sup>a</sup></bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.05(0.77, 1.42)</td>
<td align="left" rowspan="1" colspan="1">0.192</td>
<td align="left" rowspan="1" colspan="1">1.05(0.78, 1.42)</td>
<td colspan="2" align="left" rowspan="1">0.080</td>
<td align="left" rowspan="1" colspan="1">1.05(0.78, 1.41)</td>
<td align="left" rowspan="1" colspan="1">0.063</td>
<td align="left" rowspan="1" colspan="1">1.01(0.83, 1.22)</td>
<td align="left" rowspan="1" colspan="1">0.750</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Small<sup>b</sup></bold></td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">1.14(0.91, 1.42)</td>
<td align="left" rowspan="1" colspan="1">0.011</td>
<td align="left" rowspan="1" colspan="1">1.24(1.06, 1.45)<xref ref-type="table-fn" rid="nt103">*</xref></td>
<td colspan="2" align="left" rowspan="1">0.086</td>
<td align="left" rowspan="1" colspan="1">1.21(1.03, 1.42)<xref ref-type="table-fn" rid="nt103">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.019</td>
<td align="left" rowspan="1" colspan="1">0.99(0.82, 1.21)</td>
<td align="left" rowspan="1" colspan="1">0.011</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt102"><label/><p>GC: Gynecological cancer; NC: Nasopharyngeal carcinoma; GUC: Genitourinary system cancer; GIC: Gastrointestinal cancer; BC: Breast cancer; N: number of studies included; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity;</p></fn><fn id="nt103"><label>*</label><p>OR with statistical significance; a: studies with more than 500 participants; b: studies with less than 500 participants;</p></fn></table-wrap-foot></table-wrap>
<p>In the stratified analyses by cancer types, increased cancer risk was found in heterozygote comparison (CA vs. CC: OR = 1.33, 95%CI: 1.03, 1.72; P<sub>heterogeneity</sub> = 0.704) and dominant model (CA/AA vs. CC: OR = 1.32, 95% CI: 1.04, 1.69; P<sub>heterogeneity</sub> = 0.823, <xref ref-type="fig" rid="pone-0073671-g002">Figure 2</xref>) for nasopharyngeal carcinoma. As for gastrointestinal cancer, we also found that the −607 C&gt;A polymorphism was significantly associated with increased cancer risk in heterozygote comparison (CA vs. CC: OR = 1.32, 95%CI: 1.08, 1.63; P<sub>heterogeneity</sub> = 0.327) and dominant model (CA/AA vs. CC: OR = 1.25, 95% CI: 1.05, 1.50; P<sub>heterogeneity</sub> = 0.458, <xref ref-type="fig" rid="pone-0073671-g002">Figure 2</xref>). However, no significant association was observed for other cancer types (<xref ref-type="table" rid="pone-0073671-t002">Table 2</xref>). It’s worth noting that a trend of decreased risk could be drawn only in genitourinary system cancer. When stratified by source of controls, we only found a significant increased risk of cancer susceptibility in population-based studies (CA vs. CC: OR = 1.18, 95%CI: 1.01, 1.37; P<sub>heterogeneity</sub> = 0.189, <xref ref-type="supplementary-material" rid="pone.0073671.s001">Figure S1</xref>). In terms of sub-group analyses by sample size, the associations were significant in studies with small sample size among two models: heterozygote comparison (CA vs. CC: OR = 1.24, 95%CI: 1.06, 1.45; P<sub>heterogeneity</sub> = 0.086) and dominant model (CA/AA vs. CC: OR = 1.21, 95% CI: 1.03, 1.42; P<sub>heterogeneity</sub> = 0.019, <xref ref-type="supplementary-material" rid="pone.0073671.s002">Figure S2</xref>). Further analyses did not show any associations between −607 C&gt;A polymorphism and cancer risk in different ethnicities.</p>
</sec><sec id="s3c">
<title>Association of −137 G&gt;C with Cancers Risk</title>
<p>As shown in <xref ref-type="table" rid="pone-0073671-t003">Table 3</xref>, we found no significant association of the −137 G&gt;C polymorphism in IL-18 promoter region with overall cancer risk in any of four models.</p>
<table-wrap id="pone-0073671-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0073671.t003</object-id><label>Table 3</label><caption>
<title>Results from meta-analysis of −137 G&gt;C and cancer risk.</title>
</caption><alternatives><graphic id="pone-0073671-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0073671.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">CC vs. GG</td>
<td colspan="3" align="left" rowspan="1">GC vs. GG</td>
<td colspan="2" align="left" rowspan="1">GC/CC vs. GG</td>
<td colspan="2" align="left" rowspan="1">CC vs. GG/GC</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
<td colspan="2" align="left" rowspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Total</bold></td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">1.09(0.78, 1.51)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td colspan="2" align="left" rowspan="1">1.15(0.94, 1.40)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.13(0.92, 1.39)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.02(0.76, 1.37)</td>
<td align="left" rowspan="1" colspan="1">0.005</td>
</tr>
<tr>
<td colspan="11" align="left" rowspan="1"><bold>Cancer Types</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>GC</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.80(0.44, 1.47)</td>
<td align="left" rowspan="1" colspan="1">0.301</td>
<td colspan="2" align="left" rowspan="1">1.17(0.73, 1.87)</td>
<td align="left" rowspan="1" colspan="1">0.032</td>
<td align="left" rowspan="1" colspan="1">1.11(0.72, 1.73)</td>
<td align="left" rowspan="1" colspan="1">0.037</td>
<td align="left" rowspan="1" colspan="1">0.75(0.41, 1.38)</td>
<td align="left" rowspan="1" colspan="1">0.274</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>NC</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2.10(1.34, 3.29)<xref ref-type="table-fn" rid="nt105">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.538</td>
<td colspan="2" align="left" rowspan="1">1.48(1.18, 1.86)<xref ref-type="table-fn" rid="nt105">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.512</td>
<td align="left" rowspan="1" colspan="1">1.57(1.26, 1.96)<xref ref-type="table-fn" rid="nt105">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.373</td>
<td align="left" rowspan="1" colspan="1">1.82(1.17, 2.84)<xref ref-type="table-fn" rid="nt105">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.611</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>GUC</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.10(0.45, 2.72)</td>
<td align="left" rowspan="1" colspan="1">0.065</td>
<td colspan="2" align="left" rowspan="1">1.20(0.72, 2.00)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.19(0.70, 2.04)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.04(0.52, 2.09)</td>
<td align="left" rowspan="1" colspan="1">0.197</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>GIC</bold></td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.96(0.41, 2.23)</td>
<td align="left" rowspan="1" colspan="1">0.001</td>
<td colspan="2" align="left" rowspan="1">1.24(0.87, 1.76)</td>
<td align="left" rowspan="1" colspan="1">0.007</td>
<td align="left" rowspan="1" colspan="1">1.18(0.78, 1.80)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.90(0.43, 1.88)</td>
<td align="left" rowspan="1" colspan="1">0.005</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Others</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.73(0.44, 1.21)</td>
<td align="left" rowspan="1" colspan="1">0.310</td>
<td colspan="2" align="left" rowspan="1">0.68(0.30, 1.51)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.71(0.37, 1.36)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.80(0.45, 1.41)</td>
<td align="left" rowspan="1" colspan="1">0.197</td>
</tr>
<tr>
<td colspan="11" align="left" rowspan="1"><bold>Ethnicities</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Asian</bold></td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">1.13(0.72, 1.78)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.35(1.12, 1.64)<xref ref-type="table-fn" rid="nt105">*</xref></td>
<td colspan="2" align="left" rowspan="1">0.001</td>
<td align="left" rowspan="1" colspan="1">1.31(1.05, 1.64)<xref ref-type="table-fn" rid="nt105">*</xref></td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.00(0.66, 1.51)</td>
<td align="left" rowspan="1" colspan="1">0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Caucasian</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.91(0.55, 1.51)</td>
<td align="left" rowspan="1" colspan="1">0.296</td>
<td align="left" rowspan="1" colspan="1">0.64(0.33, 1.23)</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.70(0.39, 1.24)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.99(0.63, 1.54)</td>
<td align="left" rowspan="1" colspan="1">0.360</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>African</bold></td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">1.28(0.57, 2.86)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1.19(0.75, 1.87)</td>
<td colspan="2" align="left" rowspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1.20(0.78, 1.86)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1.18(0.54, 2.56)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Mixed</bold></td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.85(0.31, 2.35)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">0.74(0.48, 1.15)</td>
<td colspan="2" align="left" rowspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">0.75(0.49, 1.14)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">0.93(0.34, 2.56)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td colspan="11" align="left" rowspan="1"><bold>Source of Controls</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>PB</bold></td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">0.85(0.55, 1.33)</td>
<td align="left" rowspan="1" colspan="1">0.005</td>
<td align="left" rowspan="1" colspan="1">0.90(0.70, 1.15)</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.88(0.69, 1.13)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.87(0.58, 1.31)</td>
<td align="left" rowspan="1" colspan="1">0.013</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>HB</bold></td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">1.49(0.97, 2.27)</td>
<td align="left" rowspan="1" colspan="1">0.078</td>
<td align="left" rowspan="1" colspan="1">1.62(1.34, 1.96)<xref ref-type="table-fn" rid="nt105">*</xref></td>
<td colspan="2" align="left" rowspan="1">0.131</td>
<td align="left" rowspan="1" colspan="1">1.59(1.29, 1.97)<xref ref-type="table-fn" rid="nt105">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.033</td>
<td align="left" rowspan="1" colspan="1">1.26(0.85, 1.86)</td>
<td align="left" rowspan="1" colspan="1">0.129</td>
</tr>
<tr>
<td colspan="11" align="left" rowspan="1"><bold>Sample Size</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Large</bold><xref ref-type="table-fn" rid="nt106">a</xref></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.30(0.51, 3.27)</td>
<td align="left" rowspan="1" colspan="1">0.019</td>
<td align="left" rowspan="1" colspan="1">1.14(0.73, 1.80)</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.16(0.70, 1.92)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.27(0.60, 2.70)</td>
<td align="left" rowspan="1" colspan="1">0.073</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Small</bold><xref ref-type="table-fn" rid="nt107">b</xref></td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">1.03(0.73, 1.46)</td>
<td align="left" rowspan="1" colspan="1">0.003</td>
<td align="left" rowspan="1" colspan="1">1.14(0.91, 1.45)</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.12(0.89, 1.42)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.97(0.70, 1.33)</td>
<td align="left" rowspan="1" colspan="1">0.016</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt104"><label/><p>GC: Gynecological cancer; NC: Nasopharyngeal carcinoma; GUC: Genitourinary system cancer; GIC: Gastrointestinal cancer; N: number of studies included; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity;</p></fn><fn id="nt105"><label>*</label><p>OR with statistical significance;</p></fn><fn id="nt106"><label>a</label><p>studies with more than 500 participants;</p></fn><fn id="nt107"><label>b</label><p>studies with less than 500 participants;</p></fn></table-wrap-foot></table-wrap>
<p>When stratified by cancer types, it was found that individuals with the C allele had higher risk of nasopharyngeal carcinoma in four models : homozygote comparison (CC vs. GG: OR = 2.10, 95%CI: 1.34, 3.29; P<sub>heterogeneity</sub> = 0.538), heterozygote comparison (GC vs. GG: OR = 1.48, 95%CI: 1.18, 1.86; P<sub>heterogeneity</sub> = 0.512), dominant model (GC/CC vs. GG: OR = 1.57, 95%CI: 1.26, 1.96; P<sub>heterogeneity</sub> = 0.373, <xref ref-type="fig" rid="pone-0073671-g003">Figure 3</xref>), and recessive model (CC vs. GG/GC: OR = 1.82, 95%CI: 1.17, 2.84; P<sub>heterogeneity</sub> = 0.611). However, no significant association was observed for other cancer types (<xref ref-type="table" rid="pone-0073671-t003">Table 3</xref>). In the stratified analyses by ethnicities, the association were only significant in Asian populations for two models: heterozygote comparison (GC vs. GG: OR = 1.35, 95%CI: 1.12, 1.64; P<sub>heterogeneity</sub> = 0.001), and dominant model (GC/CC vs. GG: OR = 1.31, 95%CI: 1.05, 1.64; P<sub>heterogeneity</sub>&lt;0.001, <xref ref-type="supplementary-material" rid="pone.0073671.s003">Figure S3</xref>). In terms of sub-group analyses by the source of controls, we only found significant increased risk of cancer in hospital-based studies for two models: heterozygote comparison (GC vs. GG: OR = 1.62, 95%CI: 1.34, 1.96; P<sub>heterogeneity</sub> = 0.131), and dominant model (GC/CC vs. GG: OR = 1.59, 95%CI: 1.29, 1.97; P<sub>heterogeneity</sub> = 0.033, <xref ref-type="supplementary-material" rid="pone.0073671.s004">Figure S4</xref>). Further analyses showed no significant results in population-based studies and studies of different sample size.</p>
<fig id="pone-0073671-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0073671.g003</object-id><label>Figure 3</label><caption>
<title>Forest plot of −137 G&gt;C dominant model for overall comparison by cancer types (GC/CC vs. GG).</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0073671.g003" position="float" xlink:type="simple"/></fig></sec><sec id="s3d">
<title>IL-18 Gene Promoter Haplotypes and Cancer Risk</title>
<p>IL-18 promoter −607 C&gt;A and −137 G&gt;C polymorphisms showed strong linkage disequilibrium <xref ref-type="bibr" rid="pone.0073671-Pratesi1">[10]</xref>, <xref ref-type="bibr" rid="pone.0073671-Liu1">[12]</xref>, <xref ref-type="bibr" rid="pone.0073671-Wei1">[14]</xref>, <xref ref-type="bibr" rid="pone.0073671-Asefi1">[28]</xref>, which was also confirmed by HaploView software (version 4.2). In overall analysis, no haplotype was correlated with a significantly increased risk of overall cancers (<xref ref-type="table" rid="pone-0073671-t004">Table 4</xref>). However, when stratified by haplotypes, we found<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0073671.e001" xlink:type="simple"/></inline-formula>−607A/−137C and −607C/−137C haplotypes were associated with a significantly increased risk of nasopharyngeal carcinoma as compared with the −607C/−137G<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0073671.e002" xlink:type="simple"/></inline-formula>haplotype (−607A/−137C vs. −607C/−137G: OR = 1.26, 95%CI: 1.13, 1.40; P<sub>heterogeneity</sub> = 0.569; −607C/−137C vs. −607C/−137G: OR = 1.14, 95%CI: 1.03, 1.27; P<sub>heterogeneity</sub> = 0.775; <xref ref-type="table" rid="pone-0073671-t004">Table 4</xref>).</p>
<table-wrap id="pone-0073671-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0073671.t004</object-id><label>Table 4</label><caption>
<title>Results from meta-analysis of IL-18 gene promoter haplotypes.</title>
</caption><alternatives><graphic id="pone-0073671-t004-4" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0073671.t004" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">−607A/−137C vs. −607C/−137G</td>
<td colspan="2" align="left" rowspan="1">−607A/−137G vs. −607C/−137G</td>
<td colspan="2" align="left" rowspan="1">−607C/−137C vs. −607C/−137G</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
<td align="left" rowspan="1" colspan="1">OR</td>
<td align="left" rowspan="1" colspan="1">P<sub>h</sub></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Total</bold></td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">1.08(0.97, 1.21)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.01(0.95, 1.08)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.04(0.93, 1.17)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="8" align="left" rowspan="1"><bold>Cancer Types</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>GC</bold></td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">1.13(0.76, 1.68)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.07(0.79, 1.45)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.00(0.86, 1.17)</td>
<td align="left" rowspan="1" colspan="1">0.389</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>NC</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.26(1.13, 1.40)<xref ref-type="table-fn" rid="nt109">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.569</td>
<td align="left" rowspan="1" colspan="1">1.05(0.96, 1.16)</td>
<td align="left" rowspan="1" colspan="1">0.951</td>
<td align="left" rowspan="1" colspan="1">1.14(1.03, 1.27)<xref ref-type="table-fn" rid="nt109">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.775</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>GUC</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.99(0.83, 1.19)</td>
<td align="left" rowspan="1" colspan="1">0.008</td>
<td align="left" rowspan="1" colspan="1">0.97(0.90, 1.04)</td>
<td align="left" rowspan="1" colspan="1">0.631</td>
<td align="left" rowspan="1" colspan="1">1.06(0.92, 1.21)</td>
<td align="left" rowspan="1" colspan="1">0.051</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>GIC</bold></td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">1.17(0.94, 1.47)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.99(0.85, 1.14)</td>
<td align="left" rowspan="1" colspan="1">0.001</td>
<td align="left" rowspan="1" colspan="1">1.16(0.84, 1.59)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>BC</bold></td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">0.98(0.76, 1.27)</td>
<td align="left" rowspan="1" colspan="1">0.242</td>
<td align="left" rowspan="1" colspan="1">1.09(0.93, 1.27)</td>
<td align="left" rowspan="1" colspan="1">0.570</td>
<td align="left" rowspan="1" colspan="1">0.88(0.74, 1.04)</td>
<td align="left" rowspan="1" colspan="1">0.454</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Others</bold></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.87(0.56, 1.37)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.05(0.91, 1.20)</td>
<td align="left" rowspan="1" colspan="1">0.537</td>
<td align="left" rowspan="1" colspan="1">0.83(0.60, 1.17)</td>
<td align="left" rowspan="1" colspan="1">0.006</td>
</tr>
<tr>
<td colspan="8" align="left" rowspan="1"><bold>Ethnicities</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Asian</bold></td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">1.12(0.99, 1.26)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.03(0.96, 1.11)</td>
<td align="left" rowspan="1" colspan="1">0.006</td>
<td align="left" rowspan="1" colspan="1">1.06(0.98, 1.14)</td>
<td align="left" rowspan="1" colspan="1">0.044</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Caucasian</bold></td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.98(0.69, 1.38)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.95(0.82, 1.11)</td>
<td align="left" rowspan="1" colspan="1">0.018</td>
<td align="left" rowspan="1" colspan="1">0.98(0.64, 1.49)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>African</bold></td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">1.11(0.88, 1.38)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">1.03(0.84, 1.25)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">1.05(0.85, 1.31)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Mixed</bold></td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.81(0.56, 1.15)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">1.00(0.80, 1.24)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">0.81(0.56, 1.15)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td colspan="8" align="left" rowspan="1"><bold>Source of Controls</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>PB</bold></td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">0.97(0.83, 1.14)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.98(0.90,1.06)</td>
<td align="left" rowspan="1" colspan="1">0.003</td>
<td align="left" rowspan="1" colspan="1">0.98(0.82, 1.18)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>HB</bold></td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">1.25(1.10, 1.42)<xref ref-type="table-fn" rid="nt109">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.003</td>
<td align="left" rowspan="1" colspan="1">1.06(0.96, 1.18)</td>
<td align="left" rowspan="1" colspan="1">0.006</td>
<td align="left" rowspan="1" colspan="1">1.15(1.07, 1.23)<xref ref-type="table-fn" rid="nt109">*</xref></td>
<td align="left" rowspan="1" colspan="1">0.487</td>
</tr>
<tr>
<td colspan="8" align="left" rowspan="1"><bold>Sample Size</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Large</bold><xref ref-type="table-fn" rid="nt110">a</xref></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.06(0.84, 1.34)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.01(0.94, 1.08)</td>
<td align="left" rowspan="1" colspan="1">0.627</td>
<td align="left" rowspan="1" colspan="1">1.05(0.92, 1.21)</td>
<td align="left" rowspan="1" colspan="1">0.056</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Small</bold><xref ref-type="table-fn" rid="nt111">b</xref></td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">1.09(0.96, 1.24)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.02(0.94, 1.10)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">1.04(0.90, 1.19)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt108"><label/><p>GC: Gynecological cancer; NC: Nasopharyngeal carcinoma; GUC: Genitourinary system cancer; GIC: Gastrointestinal cancer; BC: Breast cancer; N: number of studies included; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity;</p></fn><fn id="nt109"><label>*</label><p>OR with statistical significance;</p></fn><fn id="nt110"><label>a</label><p>studies with more than 500 participants;</p></fn><fn id="nt111"><label>b</label><p>studies with less than 500 participants;</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3e">
<title>Evaluation of Heterogeneity</title>
<p>Heterogeneity between studies in each model is shown in <xref ref-type="table" rid="pone-0073671-t002">Table 2</xref> and <xref ref-type="table" rid="pone-0073671-t003">Table 3</xref>. We investigated the source of heterogeneity by covariables, such as publication years, cancer types, ethnicities, source of controls, sample size and genotyping method. As for −607 C&gt;A, although meta-regression analysis revealed that no covariables contributed to the heterogeneity across the studies in the overall result, sub-group analyses indicated that source of controls and sample size might be the main source of heterogeneity. As for −137 G&gt;C, the meta-regression analysis revealed that cancer types (p = 0.039), but not other covariables contributed to the heterogeneity across studies in the overall result, which was in consistent with sub-group analyses.</p>
</sec><sec id="s3f">
<title>Sensitivity Analyses and Publication Bias</title>
<p>Sensitivity analysis was performed to estimate individual study’s influence on the pooled ORs by deleting one single study each time from pooled analysis, and the corresponding pooled ORs were not materially altered, suggesting stability of the meta-analyses (<xref ref-type="supplementary-material" rid="pone.0073671.s005">Figure S5</xref> and <xref ref-type="supplementary-material" rid="pone.0073671.s006">Figure S6</xref>). Publication bias was assessed by Begg’s funnel plot and Egger’s test. Begg’s funnel plot was both roughly symmetrical for two polymorphisms (<xref ref-type="fig" rid="pone-0073671-g004">Figure 4</xref>.A and <xref ref-type="fig" rid="pone-0073671-g005">Figure 5</xref>). Egger’s test was then performed for statistical test, no publication bias was detected for −137 G&gt;C (p = 0.842), but −607 C&gt;A failed (p = 0.009). Further analysis revealed that the study reported by Qi and colleagues <xref ref-type="bibr" rid="pone.0073671-Qi1">[15]</xref> was responsible for the asymmetry of funnel plot (<xref ref-type="fig" rid="pone-0073671-g004">Figure 4</xref>.A). When this study was deleted, there was no evidence of publication bias for −607 C&gt;A (p = 0.103, <xref ref-type="fig" rid="pone-0073671-g004">Figure 4</xref>.B), while the pooled OR was marginally significant (OR = 1.14, 95% CI: 1.00, 1.30).</p>
<fig id="pone-0073671-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0073671.g004</object-id><label>Figure 4</label><caption>
<title>Funnel plot analysis to detect publication bias for −607 C&gt;A.</title>
<p>A: funnel plot of all 23 eligible studies on −607 C&gt;A, Egger’s test p = 0.009. B: funnel plot of 22 studies on −607 C&gt;A (Qi’s study was excluded), Egger’s test p = 0.103. The circles represent the weight of individual study.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0073671.g004" position="float" xlink:type="simple"/></fig><fig id="pone-0073671-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0073671.g005</object-id><label>Figure 5</label><caption>
<title>Funnel plot analysis to detect publication bias for −137 G&gt;C. The circles represent the weight of individual study.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0073671.g005" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s4">
<title>Discussion</title>
<p>To our knowledge, this is the first meta-analysis to explore the association between IL-18 gene promoter polymorphisms (−607 C&gt;A and −137 G&gt;C) and cancer risk. In the present meta-analysis, 26 eligible studies including 4096 cases and 5222 controls, were identified and analyzed. We demonstrated that IL-18 gene promoter −607 C&gt;A polymorphism was associated with a statistical increased risk of cancer susceptibility in the variant CA heterozygote and CA/AA genotype compared with the CC wild type homozygote, especially in nasopharyngeal carcinoma and gastrointestinal cancer, however, an opposite trend was found in genitourinary system cancer. Although no significant association for −137 G&gt;C was observed with overall cancer risk, it is also worth noting that the association was significant in Asian populations, especially in nasopharyngeal carcinoma.</p>
<p>IL-18 is a 18.3kDa multifunctional cytokine and generally referred to as a member of the IL-1 family. IL-18 can enhance the production of IFN-γ by T cells and NK cells and augment the cytolytic activity of NK cells and cytotoxic T lymphocytes <xref ref-type="bibr" rid="pone.0073671-Nakanishi1">[41]</xref>, <xref ref-type="bibr" rid="pone.0073671-Gracie1">[42]</xref>. It can also affect the differentiation of CD4+ and CD8+ T cells, and acts synergistically with other cytokines such as IL-12 to induce the production of IFN-γ and stimulate Th1 immune response <xref ref-type="bibr" rid="pone.0073671-Srivastava1">[3]</xref>. Recently, many studies indicated that IL-18 might be closely related to the pathogenesis of tumors. The specific and non-specific anti-tumor effects were confirmed in IL-18 gene transfected dendritic cells and breast cancer cells <xref ref-type="bibr" rid="pone.0073671-Xia1">[43]</xref>, <xref ref-type="bibr" rid="pone.0073671-Han1">[44]</xref>. In addition, it has been reported that serum IL-18 level may be used as a marker for monitoring the clinical course of patients with some cancer types, including esophageal, breast and gastric cancer<xref ref-type="bibr" rid="pone.0073671-Eissa1">[45]</xref>–<xref ref-type="bibr" rid="pone.0073671-ThongNgam1">[47]</xref>. It has shown that the polymorphisms of IL-18 could influence gene activity and expression of IL-18 <xref ref-type="bibr" rid="pone.0073671-Giedraitis1">[9]</xref>. Together with the critical role of IL-18 in cancer immunity regulation, the polymorphisms of IL-18 would be related to cancer risks.</p>
<p>Among 23 eligible studies based on −607 C&gt;A, we found a significant increased risk in the heterozygote comparison (CA vs. CC) and dominant model (CA/AA vs. CC) for nasopharyngeal carcinoma and gastrointestinal cancer, including colorectal cancer <xref ref-type="bibr" rid="pone.0073671-Nikiteas1">[13]</xref>, <xref ref-type="bibr" rid="pone.0073671-Haghshenas1">[29]</xref>, <xref ref-type="bibr" rid="pone.0073671-Guo1">[37]</xref>, esophageal carcinoma <xref ref-type="bibr" rid="pone.0073671-Wei1">[14]</xref>, <xref ref-type="bibr" rid="pone.0073671-Babar1">[36]</xref> and stomach cancer <xref ref-type="bibr" rid="pone.0073671-Haghshenas1">[29]</xref>, which was in consistent with our pooled analysis of overall cancer risk. However, a trend of reduced cancer risk was found in genitourinary system cancer, including prostate cancer <xref ref-type="bibr" rid="pone.0073671-Liu1">[12]</xref>, <xref ref-type="bibr" rid="pone.0073671-Liu2">[40]</xref>, renal cell carcinoma <xref ref-type="bibr" rid="pone.0073671-SaenzLopez1">[33]</xref> and bladder cancer <xref ref-type="bibr" rid="pone.0073671-Jaiswal1">[39]</xref>. These results suggested that the variant CA and CA/AA genotypes of IL-18 gene promoter −607 C&gt;A polymorphism were definitive associated with cancer susceptibility, especially in nasopharyngeal carcinoma and gastrointestinal cancer. In the sub-group analyses of ethnicities, no significant association except a trend of increased cancer risk was found in Asians and Caucasians. However, Jaiswal’s study was the only study which reported that the CA/AA genotype could be associated with reduced cancer risk in Asians <xref ref-type="bibr" rid="pone.0073671-Jaiswal1">[39]</xref>. The contrary individual result might be attributed to the discrepancy between bladder and other cancers. So we found that cancer types greatly affected the association between IL-18 gene promoter −607 C&gt;A polymorphism and cancer risk, but ethnicities failed.</p>
<p>Among 21 eligible studies based on −137 G&gt;C, carriers of the variant C allele were only reported with a significantly increased cancer risk compared with those of G allele in nasopharyngeal carcinoma <xref ref-type="bibr" rid="pone.0073671-Pratesi1">[10]</xref>, <xref ref-type="bibr" rid="pone.0073671-Farhat1">[11]</xref>, <xref ref-type="bibr" rid="pone.0073671-Nong1">[31]</xref>, <xref ref-type="bibr" rid="pone.0073671-Du1">[38]</xref>. In dominant model, although many single studies suggested −137 G&gt;C polymorphism significantly contributed to the susceptibility of other cancer types, including cervical <xref ref-type="bibr" rid="pone.0073671-Sobti1">[26]</xref>, prostate <xref ref-type="bibr" rid="pone.0073671-Liu1">[12]</xref>, bladder <xref ref-type="bibr" rid="pone.0073671-Jaiswal1">[39]</xref>, esophageal <xref ref-type="bibr" rid="pone.0073671-Wei1">[14]</xref> and colorectal cancer <xref ref-type="bibr" rid="pone.0073671-Guo1">[37]</xref>, the pooled ORs failed to confirm the association in each corresponding group classified by cancer types. Furthermore, Monroy and colleagues found significantly reduced cancer risk with GC/CC genotype in hodgkin disease <xref ref-type="bibr" rid="pone.0073671-Monroy1">[34]</xref>. This is the only negative result among all eligible studies. In the sub-group analysis of cancer types, no significant association was found except for four models of nasopharyngeal carcinoma. Moreover, the −607A/−137C and −607C/−137C haplotypes were significantly associated with the risk of nasopharyngeal carcinoma. Notably, both haplotypes included a variant −137C allele. This finding suggests that the IL-18 −137 G&gt;C polymorphism could be used as a genetic susceptibility marker of nasopharyngeal carcinoma. But for the four studies of genitourinary system cancer, two of them found significant increased risk with C variant allele carriers <xref ref-type="bibr" rid="pone.0073671-Liu1">[12]</xref>, <xref ref-type="bibr" rid="pone.0073671-Jaiswal1">[39]</xref>, while the other two of them found a trend of reduced cancer risk in contrast <xref ref-type="bibr" rid="pone.0073671-SaenzLopez1">[33]</xref>, <xref ref-type="bibr" rid="pone.0073671-Liu2">[40]</xref>. Likewise, no significant association was detected in gastrointestinal cancer, while two of them found significant increased cancer risk <xref ref-type="bibr" rid="pone.0073671-Wei1">[14]</xref>, <xref ref-type="bibr" rid="pone.0073671-Guo1">[37]</xref>, the other three studies found a trend of reduced cancer risk <xref ref-type="bibr" rid="pone.0073671-Haghshenas1">[29]</xref>, <xref ref-type="bibr" rid="pone.0073671-Babar1">[36]</xref>.This discrepancy may be explained by the reason that the detailed pathology types were different. Moreover, ethnicity might be also an important reason, because the studies which reported increased cancer risk were all most carried out in Asians. We also found the association between the −137 G&gt;C and cancer risk was significant in Asians, but a trend of reduced cancer risk was found in Caucasians. The differences might be explained by genetic diversities, such as different risk factors in life styles, and various of environmental exposure. Additionally, in the sub-group analysis of the source of controls, the positive result was only observed in hospital-based studies, but not in population-based studies. However, the hospital-based controls might not represent of the general population, thus there was a low chance of selection bias.</p>
<p>As for the aforementioned publication bias detected by Egger’ test (CA/AA vs. CC) for −607 C&gt;A, Qi’s study <xref ref-type="bibr" rid="pone.0073671-Qi1">[15]</xref>was responsible for the bias. However, when we excluded it, the pooled OR was marginally significant (OR = 1.14, 95% CI: 1.00, 1.30). Thus we speculated that the publication bias we detected might contribute to publishing positive results. Therefore, it is expected that more studies are required to confirm the pooled OR in this meta-analysis, and the funnel plot will be more symmetrical and no publication bias will be detected.</p>
<p>For heterogeneity, we found that sample size was the main source of heterogeneity for both polymorphisms. The studies with small sample size may contribute to a small-study effect, in which effects reported are larger, and lead to between studies variance. However, this kind of heterogeneity is hard to exclude, because recruitment of enough cases with specific cancer type is difficult.</p>
<p>In this meta-analysis, we included 4096 cases and 5222 controls, which can provide enough statistical power and strengthen the reliability of our results. In addition, several limitations should be considered: First, detailed individual data was not available, and a more precise analysis should be conducted on other covariates such as age, sex, and environmental factors. Secondly, the sample size was relatively small for some sub-group analyses. Thirdly, a tiny publication bias for −607 C&gt;A excited in this meta-analysis.</p>
<p>In conclusion, we demonstrate that IL-18 gene promoter −607 C&gt;A polymorphism is significantly associated with overall cancer risk, especially in nasopharyngeal carcinoma and gastrointestinal cancer; and the −137 G&gt;C polymorphism is associated with increased overall cancer risk in Asian populations and also significantly increase the risk of nasopharyngeal carcinoma. Future large-scale studies are required to validate the current findings.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0073671.s001" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0073671.s001" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p><bold>Forest plot of −607 C&gt;A heterozygote comparison for overall comparison by source of controls (CA vs. CC).</bold></p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0073671.s002" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0073671.s002" position="float" xlink:type="simple"><label>Figure S2</label><caption>
<p><bold>Forest plot of −607 C&gt;A dominant model for overall comparison by sample size (CA/AA vs. CC).</bold></p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0073671.s003" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0073671.s003" position="float" xlink:type="simple"><label>Figure S3</label><caption>
<p><bold>Forest plot of −137 G&gt;C dominant model for overall comparison by ethnicities (GC/CC vs. GG).</bold></p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0073671.s004" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0073671.s004" position="float" xlink:type="simple"><label>Figure S4</label><caption>
<p><bold>Forest plot of −137 G&gt;C dominant model for overall comparison by source of controls (GC/CC vs. GG).</bold></p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0073671.s005" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0073671.s005" position="float" xlink:type="simple"><label>Figure S5</label><caption>
<p><bold>Sensitivity Analyses for −607 C&gt;A.</bold> The pooled odds ratios were calculated by omitting each data set at a time.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0073671.s006" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0073671.s006" position="float" xlink:type="simple"><label>Figure S6</label><caption>
<p><bold>Sensitivity Analyses for −137 G&gt;C.</bold> The pooled odds ratios were calculated by omitting each data set at a time.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0073671.s007" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0073671.s007" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p><bold>PRISMA checklist.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0073671-Chang1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Segal</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Nakanishi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Okamura</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Shevach</surname><given-names>EM</given-names></name> (<year>2000</year>) <article-title>The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit</article-title>. <source>Eur J Immunol</source> <volume>30</volume>: <fpage>1113</fpage>–<lpage>1119</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Tschoeke1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tschoeke</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Oberholzer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moldawer</surname><given-names>LL</given-names></name> (<year>2006</year>) <article-title>Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis</article-title>. <source>Crit Care Med</source> <volume>34</volume>: <fpage>1225</fpage>–<lpage>1233</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Srivastava1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Srivastava</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Salim</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Robertson</surname><given-names>MJ</given-names></name> (<year>2010</year>) <article-title>Interleukin-18: biology and role in the immunotherapy of cancer</article-title>. <source>Curr Med Chem</source> <volume>17</volume>: <fpage>3353</fpage>–<lpage>3357</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Gunel1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gunel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Coskun</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Sancak</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gunel</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Hasdemir</surname><given-names>O</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients</article-title>. <source>Cancer</source> <volume>95</volume>: <fpage>663</fpage>–<lpage>667</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Iwasaki1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iwasaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tsujimura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kashiwamura</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tsutsui</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice</article-title>. <source>J Immunother</source> <volume>25</volume> Suppl 1<fpage>S52</fpage>–<lpage>60</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Okano1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Okano</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>K</given-names></name> (<year>2000</year>) <article-title>Canine interleukin-18 induces apoptosis and enhances Fas ligand mRNA expression in a canine carcinoma cell line</article-title>. <source>Anticancer Res</source> <volume>20</volume>: <fpage>3411</fpage>–<lpage>3415</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Park1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Morel</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Amin</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Connors</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Harlow</surname><given-names>LA</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Evidence of IL-18 as a novel angiogenic mediator</article-title>. <source>J Immunol</source> <volume>167</volume>: <fpage>1644</fpage>–<lpage>1653</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Park2"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cheon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>D</given-names></name> (<year>2007</year>) <article-title>The dual effects of interleukin-18 in tumor progression</article-title>. <source>Cell Mol Immunol</source> <volume>4</volume>: <fpage>329</fpage>–<lpage>335</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Giedraitis1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Giedraitis</surname><given-names>V</given-names></name>, <name name-style="western"><surname>He</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>WX</given-names></name>, <name name-style="western"><surname>Hillert</surname><given-names>J</given-names></name> (<year>2001</year>) <article-title>Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation</article-title>. <source>J Neuroimmunol</source> <volume>112</volume>: <fpage>146</fpage>–<lpage>152</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Pratesi1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pratesi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bortolin</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Bidoli</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tedeschi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Vaccher</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type</article-title>. <source>Cancer Immunol Immunother</source> <volume>55</volume>: <fpage>23</fpage>–<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Farhat1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farhat</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hassen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bouzgarrou</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gabbouj</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bouaouina</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients</article-title>. <source>Cytokine</source> <volume>43</volume>: <fpage>132</fpage>–<lpage>137</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Liu1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>G</given-names></name> (<year>2007</year>) <article-title>Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer</article-title>. <source>DNA Cell Biol</source> <volume>26</volume>: <fpage>613</fpage>–<lpage>618</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Nikiteas1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nikiteas</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yannopoulos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chatzitheofylaktou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tsigris</surname><given-names>C</given-names></name> (<year>2007</year>) <article-title>Heterozygosity for interleukin-18–607 A/C polymorphism is associated with risk for colorectal cancer</article-title>. <source>Anticancer Res</source> <volume>27</volume>: <fpage>3849</fpage>–<lpage>3853</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Wei1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Lan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>RG</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma</article-title>. <source>Acta Oncol</source> <volume>46</volume>: <fpage>1090</fpage>–<lpage>1096</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Qi1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>J</given-names></name> (<year>2008</year>) <article-title>[Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer]</article-title>. <source>Nan Fang Yi Ke Da Xue Xue Bao</source> <volume>28</volume>: <fpage>754</fpage>–<lpage>757</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-KhaliliAzad1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khalili-Azad</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Razmkhah</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ghiam</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Doroudchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Talei</surname><given-names>AR</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Association of interleukin-18 gene promoter polymorphisms with breast cancer</article-title>. <source>Neoplasma</source> <volume>56</volume>: <fpage>22</fpage>–<lpage>25</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Pan1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pan</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Leng</surname><given-names>RX</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>DQ</given-names></name> (<year>2011</year>) <article-title>Lack of association of interleukin-18 gene promoter −607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis</article-title>. <source>Lupus</source> <volume>20</volume>: <fpage>945</fpage>–<lpage>951</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Qiu1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qiu</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>XX</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Hsa-miR-499 rs3746444 Polymorphism Contributes to Cancer Risk: A Meta-Analysis of 12 Studies</article-title>. <source>PLOS ONE</source> <volume>7</volume>: <fpage>e50887</fpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Boissel1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boissel</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Sacks</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Leizorovicz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Blanchard</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Panak</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>1988</year>) <article-title>Meta-analysis of clinical trials: summary of an international conference</article-title>. <source>Eur J Clin Pharmacol</source> <volume>34</volume>: <fpage>535</fpage>–<lpage>538</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Lau1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lau</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ioannidis</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Schmid</surname><given-names>CH</given-names></name> (<year>1997</year>) <article-title>Quantitative synthesis in systematic reviews</article-title>. <source>Ann Intern Med</source> <volume>127</volume>: <fpage>820</fpage>–<lpage>826</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Begg1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Egger1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Bushley1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bushley</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Ferrell</surname><given-names>R</given-names></name>, <name name-style="western"><surname>McDuffie</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Terada</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Carney</surname><given-names>ME</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer</article-title>. <source>Gynecol Oncol</source> <volume>95</volume>: <fpage>672</fpage>–<lpage>679</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Vairaktaris1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vairaktaris</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Serefoglou</surname><given-names>ZC</given-names></name>, <name name-style="western"><surname>Yapijakis</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Agapi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vassiliou</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>The interleukin-18-607A/C polymorphism is not associated with risk for oral cancer</article-title>. <source>Anticancer Res</source> <volume>27</volume>: <fpage>4011</fpage>–<lpage>4014</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Yang1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Pin</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>W</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>[Association of interleukin-18 gene rs1946519 and rs360718 single nucleotide polymorphism with cervical cancer]</article-title>. <source>Nan Fang Yi Ke Da Xue Xue Bao</source> <volume>27</volume>: <fpage>1006</fpage>–<lpage>1008</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Sobti1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sobti</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Shekari</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tamandani</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Malekzadeh</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Suri</surname><given-names>V</given-names></name> (<year>2008</year>) <article-title>Association of interleukin-18 gene promoter polymorphism on the risk of cervix carcinogenesis in north Indian population</article-title>. <source>Oncol Res</source> <volume>17</volume>: <fpage>159</fpage>–<lpage>166</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Kashef1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kashef</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Dehaghani</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Naeimi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fattahi</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Ghaderi</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Interleukin-18 gene promoter polymorphisms in women with gestational trophoblastic diseases</article-title>. <source>J Reprod Med</source> <volume>53</volume>: <fpage>853</fpage>–<lpage>859</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Asefi1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Asefi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mojtahedi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Khademi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Naeimi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ghaderi</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study</article-title>. <source>J Laryngol Otol</source> <volume>123</volume>: <fpage>444</fpage>–<lpage>448</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Haghshenas1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haghshenas</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Hosseini</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Mahmoudi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Saberi-Firozi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Farjadian</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers</article-title>. <source>J Gastroenterol Hepatol</source> <volume>24</volume>: <fpage>1119</fpage>–<lpage>1122</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Samsami1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Samsami</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Shahriary</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kashef</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Naeimi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fattahi</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Interleukin-18 gene promoter and serum level in women with ovarian cancer</article-title>. <source>Mol Biol Rep</source> <volume>36</volume>: <fpage>2393</fpage>–<lpage>2397</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Nong1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nong</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nong</surname><given-names>HB</given-names></name> (<year>2009</year>) <article-title>Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population</article-title>. <source>DNA Cell Biol</source> <volume>28</volume>: <fpage>507</fpage>–<lpage>513</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Farjadfar1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farjadfar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mojtahedi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ghayumi</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Erfani</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Haghshenas</surname><given-names>MR</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study</article-title>. <source>Acta Oncol</source> <volume>48</volume>: <fpage>971</fpage>–<lpage>976</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-SaenzLopez1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saenz-Lopez</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Carretero</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Vazquez</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sanchez</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients</article-title>. <source>Hum Immunol</source> <volume>71</volume>: <fpage>309</fpage>–<lpage>313</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Monroy1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Monroy</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Cortes</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>D’Amelio</surname><given-names>AM</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Etzel</surname><given-names>CJ</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes</article-title>. <source>Mol Carcinog</source> <volume>50</volume>: <fpage>36</fpage>–<lpage>46</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Taheri1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taheri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hashemi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Eskandari-Nasab</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fazaeli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Arababi</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Association of −607 C/A polymorphism of IL-18 gene (rs1946518) with breast cancer risk in Zahedan, Southeast Iran</article-title>. <source>Prague Med Rep</source> <volume>113</volume>: <fpage>217</fpage>–<lpage>222</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Babar1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Babar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Segurado</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Genes of the interleukin-18 pathway are associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma</article-title>. <source>Am J Gastroenterol</source> <volume>107</volume>: <fpage>1331</fpage>–<lpage>1341</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Guo1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>AQ</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>FD</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>[Association of the IL-18 gene polymorphism with susceptibility to colorectal cancer]</article-title>. <source>Zhonghua Wei Chang Wai Ke Za Zhi</source> <volume>15</volume>: <fpage>400</fpage>–<lpage>403</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Du1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Du</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>YS</given-names></name> (<year>2012</year>) <article-title>Interleukin-18 gene genetic polymorphisms and risk of nasopharyngeal carcinoma in Han population from Sichuan China</article-title>. <source>Med J west China</source> <volume>24</volume>: <fpage>1683</fpage>–<lpage>1685</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Jaiswal1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jaiswal</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Srivastava</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mittal</surname><given-names>RD</given-names></name> (<year>2013</year>) <article-title>Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population</article-title>. <source>Gene</source> <volume>519</volume>: <fpage>128</fpage>–<lpage>134</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Liu2"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>He</surname><given-names>YZ</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Effect of IL-18 gene promoter polymorphisms on prostate cancer occurrence and prognosis in Han Chinese population</article-title>. <source>Genet Mol Res</source> <volume>12</volume>: <fpage>820</fpage>–<lpage>829</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Nakanishi1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakanishi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yoshimoto</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tsutsui</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Okamura</surname><given-names>H</given-names></name> (<year>2001</year>) <article-title>Interleukin-18 regulates both Th1 and Th2 responses</article-title>. <source>Annu Rev Immunol</source> <volume>19</volume>: <fpage>423</fpage>–<lpage>474</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Gracie1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gracie</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Robertson</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>McInnes</surname><given-names>IB</given-names></name> (<year>2003</year>) <article-title>Interleukin-18</article-title>. <source>J Leukoc Biol</source> <volume>73</volume>: <fpage>213</fpage>–<lpage>224</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Xia1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xia</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>J</given-names></name> (<year>2004</year>) <article-title>Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity</article-title>. <source>Cancer Biother Radiopharm</source> <volume>19</volume>: <fpage>322</fpage>–<lpage>330</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Han1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Han</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>QS</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Study on interleukin-18 gene transfer into human breast cancer cells to prevent tumorigenicity</article-title>. <source>J Zhejiang Univ Sci</source> <volume>5</volume>: <fpage>472</fpage>–<lpage>476</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Eissa1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eissa</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Zaki</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>El-Maghraby</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Kadry</surname><given-names>DY</given-names></name> (<year>2005</year>) <article-title>Importance of serum IL-18 and RANTES as markers for breast carcinoma progression</article-title>. <source>J Egypt Natl Canc Inst</source> <volume>17</volume>: <fpage>51</fpage>–<lpage>55</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-Tsuboi1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsuboi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Miyazaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nakajima</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fukai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Masuda</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma</article-title>. <source>Cancer Lett</source> <volume>205</volume>: <fpage>207</fpage>–<lpage>214</lpage>.</mixed-citation>
</ref>
<ref id="pone.0073671-ThongNgam1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thong-Ngam</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tangkijvanich</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lerknimitr</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mahachai</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Theamboonlers</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Diagnostic role of serum interleukin-18 in gastric cancer patients</article-title>. <source>World J Gastroenterol</source> <volume>12</volume>: <fpage>4473</fpage>–<lpage>4477</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>